Literature DB >> 16434909

Unforeseen inpatient mortality among veterans with schizophrenia.

Laurel A Copeland1, John E Zeber, Robert A Rosenheck, Alexander L Miller.   

Abstract

BACKGROUND: Patients with schizophrenia have co-occurring medical conditions, like other patients, but may lack the capacity to provide good self-care or to work with their providers to ensure appropriate medical treatment. We hypothesized that death among patients with schizophrenia occurs more frequently after minimal care of comorbid conditions.
METHODS: All patients who died in veterans affairs (VA) hospitals during FY02 were categorized as to type of death: unforeseen (age <80 years, 1-2 inpatient days past year), cancer, organ failure (heart, lungs, kidneys), frailty (dementias, hip fractures, dehydration, etc.), or other deaths. Logistic regression explored factors in unforeseen death.
RESULTS: During the year, 27,798 patients died in VA facilities; 3% had schizophrenia (n = 943). Roughly two-thirds of all deaths were from cancer or organ failure, 11% frailty, 9% other, and 8% met criteria for unforeseen death. Among patients with schizophrenia, however, 20% fell into the unforeseen death category. In an adjusted model, schizophrenia was associated with a 2-fold increased risk of unforeseen death compared with any other category (odds ratio = 2.4, 95% confidence interval 1.6-3.4). Unforeseen death was less likely among patients with substance abuse diagnoses in the year before death and more likely when patients had no outpatient medical care.
CONCLUSIONS: VA patients with schizophrenia were more likely to die as inpatients with little previous-year care compared with other inpatient decedents without schizophrenia. Outreach efforts may be necessary to engage patients with schizophrenia in treatment of potentially life-threatening conditions.

Entities:  

Mesh:

Year:  2006        PMID: 16434909     DOI: 10.1097/01.mlr.0000196973.99080.fb

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  14 in total

1.  Reengaging veterans with serious mental illness into care: preliminary results from a national randomized trial.

Authors:  Amy M Kilbourne; David E Goodrich; Zongshan Lai; Daniel Almirall; Kristina M Nord; Nicholas W Bowersox; Kristen M Abraham
Journal:  Psychiatr Serv       Date:  2014-11-17       Impact factor: 3.084

2.  Reduced mortality among Department of Veterans Affairs patients with schizophrenia or bipolar disorder lost to follow-up and engaged in active outreach to return for care.

Authors:  Chester L Davis; Amy M Kilbourne; Frederic C Blow; John R Pierce; Bernard M Winkel; Edward Huycke; Robert Langberg; David Lyle; Yancy Phillips; Stephanie Visnic
Journal:  Am J Public Health       Date:  2012-01-25       Impact factor: 9.308

3.  Eight-year trends of cardiometabolic morbidity and mortality in patients with schizophrenia.

Authors:  Nancy E Morden; Zongshan Lai; David E Goodrich; Todd MacKenzie; John F McCarthy; Karen Austin; Deborah E Welsh; Stephen Bartels; Amy M Kilbourne
Journal:  Gen Hosp Psychiatry       Date:  2012-04-18       Impact factor: 3.238

4.  Implementing Effective Policy in a National Mental Health Reengagement Program for Veterans.

Authors:  Shawna N Smith; Zongshan Lai; Daniel Almirall; David E Goodrich; Kristen M Abraham; Kristina M Nord; Amy M Kilbourne
Journal:  J Nerv Ment Dis       Date:  2017-02       Impact factor: 2.254

5.  Patterns of primary care and mortality among patients with schizophrenia or diabetes: a cluster analysis approach to the retrospective study of healthcare utilization.

Authors:  Laurel A Copeland; John E Zeber; Chen-Pin Wang; Michael L Parchman; Valerie A Lawrence; Marcia Valenstein; Alexander L Miller
Journal:  BMC Health Serv Res       Date:  2009-07-26       Impact factor: 2.655

6.  Disparities of care for African-Americans and Caucasians with community-acquired pneumonia: a retrospective cohort study.

Authors:  Christopher R Frei; Eric M Mortensen; Laurel A Copeland; Russell T Attridge; Mary Jo V Pugh; Marcos I Restrepo; Antonio Anzueto; Brandy Nakashima; Michael J Fine
Journal:  BMC Health Serv Res       Date:  2010-05-27       Impact factor: 2.655

7.  Do patients with schizophrenia receive state-of-the-art lung cancer therapy? A brief report.

Authors:  Farrah J Mateen; Aminah Jatoi; Timothy W Lineberry; Dawn Aranguren; Edward T Creagan; Gary A Croghan; James R Jett; Randolph S Marks; Julian R Molina; Ronald L Richardson
Journal:  Psychooncology       Date:  2008-07       Impact factor: 3.894

8.  Leading from the middle: replication of a re-engagement program for veterans with mental disorders lost to follow-up care.

Authors:  David E Goodrich; Nicholas W Bowersox; Kristen M Abraham; Jeffrey P Burk; Stephanie Visnic; Zongshan Lai; Amy M Kilbourne
Journal:  Depress Res Treat       Date:  2012-09-25

9.  Cluster randomized adaptive implementation trial comparing a standard versus enhanced implementation intervention to improve uptake of an effective re-engagement program for patients with serious mental illness.

Authors:  Amy M Kilbourne; Kristen M Abraham; David E Goodrich; Nicholas W Bowersox; Daniel Almirall; Zongshan Lai; Kristina M Nord
Journal:  Implement Sci       Date:  2013-11-20       Impact factor: 7.327

10.  Mortality and guideline-concordant care for older patients with schizophrenia: a retrospective longitudinal study.

Authors:  Jack Y Tsan; Eileen M Stock; Jazmin M Gonzalez; David S Greenawalt; John E Zeber; Emran Rouf; Laurel A Copeland
Journal:  BMC Med       Date:  2012-11-26       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.